Ten Lessons Bioprocessing Can Teach Us About Cell and Gene Therapy

floating white paper

The development of cell and gene therapies (CGTs) is rapidly increasing. CGTs have many of the same manufacturing needs as biopharmaceuticals, in fact, they both use single-use technologies (SUTs) for reduced costs, time savings and sterility. But for CGTs, many SUTs cannot be transferred from laboratory scale into commercial manufacturing for a variety of reasons. Read our white paper to learn about these challenges and how SUTs in biopharmaceutical manufacturing may offer part of the solution – particularly in the area of connection technologies.

Learn how:

  • Bioprocessing and CGT processes are similar and different
  • The process setting influences the type of connection technology used
  • An aseptic connector produces a sterile connection in a non-sterile environment

Fill in the form to download the Cell & Gene Therapies: A Guide To Single-Use Connections – 10 Transferable Lessons From The Bioprocessing Industry to learn more.

/Portals/0/Library/Resources/Literature/WhitePapers/Documents/CPC-cell-gene-therapies_white-paper.pdf CPC-cell-gene-therapies_white-paper.pdf

Contact Us